Author:
Weidemann F.,Störk S.,Sommer C.,Üçeyler N.,Ertl G.,Wanner C.,Krämer J.
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Reference30 articles.
1. Fabry J (1898) Ein Beitrag Zur Kenntnis der Purpura haemorrhagica nodularis (Purpura papulosa hemorrhagica Habrae). Arch Dermatol Syph 43:187
2. Weidemann F, Sanchez-Nino MD, Politei J et al (2013) Fibrosis: a key feature of Fabry disease with potential therapeutic implications. Orphanet J Rare Dis 8:116
3. Desnick RJ, Ioannou YA, Eng CM (2001) Alpha-galactosidase A deficiency: Fabry disease. In: Scriver C, Beaudet A, Sly W, Valle D (Hrsg) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York
4. Mechtler TP, Stary S, Metz TF et al (2012) Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria. Lancet 379:335–341
5. Palacek T, Honzikova J, Poupetova H et al (2014) Prevalence of Fabry disease in male patients with unexplained left ventricular hypertrophy in primary cardiology practice: prospective Fabry cardiomyopathy screening study (FACSS). J Inherit Metab Dis 37:455–460